Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 163

1.

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.

Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group.

Ann Intern Med. 2005 Mar 1;142(5):323-32.PMID: 15738451 [PubMed - indexed for MEDLINE]Related articlesFree article

2.

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.

Eddy DM, Schlessinger L, Kahn R.

Ann Intern Med. 2005 Aug 16;143(4):251-64.PMID: 16103469 [PubMed - indexed for MEDLINE]Related articlesFree article

3.

Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.

Diabetes Prevention Program Research Group.

Diabetes Care. 2003 Sep;26(9):2518-23.PMID: 12941712 [PubMed - indexed for MEDLINE]Related articlesFree article

5.

Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.

[No authors listed]

Ann Intern Med. 2005 Mar 1;142(5):I28. No abstract available. PMID: 15738446 [PubMed - indexed for MEDLINE]Related articlesFree article

6.

Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.

Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM; Diabetes Prevention Program Research Group.

Diabetes Care. 2003 Jan;26(1):36-47.PMID: 12502656 [PubMed - indexed for MEDLINE]Related articlesFree article

7.

[Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]

Flórez H.

Invest Clin. 1997 Mar;38(1):39-52. Review. Spanish. PMID: 9235072 [PubMed - indexed for MEDLINE]Related articles

8.

Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.

Caro JJ, Getsios D, Caro I, Klittich WS, O'Brien JA.

Diabet Med. 2004 Nov;21(11):1229-36.PMID: 15498090 [PubMed - indexed for MEDLINE]Related articles

9.

An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.

Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.

Diabetes Care. 2006 Jun;29(6):1237-41.PMID: 16732002 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.

[No authors listed]

JAMA. 1998 Nov 25;280(20):1757-63. Erratum in: JAMA 1999 Jan 27;281(4):325. PMID: 9842951 [PubMed - indexed for MEDLINE]Related articlesFree article

11.

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articles

12.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.PMID: 15147610 [PubMed - indexed for MEDLINE]Related articlesFree article

13.

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.

Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R.

J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075-81.PMID: 17077202 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group.

Ann Intern Med. 2005 Apr 19;142(8):611-9.PMID: 15838067 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

CDC Diabetes Cost-effectiveness Group.

JAMA. 2002 May 15;287(19):2542-51.PMID: 12020335 [PubMed - indexed for MEDLINE]Related articlesFree article

16.

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis.

Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, Davies MJ, Khunti K.

BMJ. 2008 May 24;336(7654):1180-5. Epub 2008 Apr 21.PMID: 18426840 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.

Shearer AT, Bagust A, Ampudia-Blasco FJ, Martínez-Lage Alvarez B, Pérez Escolano I, París G.

Pharmacoeconomics. 2006;24 Suppl 1:49-59. Review.PMID: 16800162 [PubMed - indexed for MEDLINE]Related articles

18.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Hornberger J, Robertus K.

Ann Intern Med. 2006 Sep 5;145(5):317-25.PMID: 16954357 [PubMed - indexed for MEDLINE]Related articlesFree article

19.

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group.

N Engl J Med. 2002 Feb 7;346(6):393-403.PMID: 11832527 [PubMed - indexed for MEDLINE]Related articlesFree article

20.

An update on the Diabetes Prevention Program.

Ratner RE; Diabetes Prevention Program Research.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:20-4. Review.PMID: 16627375 [PubMed - indexed for MEDLINE]Related articlesFree article

Supplemental Content

Find related data